![Petmedix logo web.png](https://www.bioindustry.org/static/dfce4740-0547-4318-8e0b6498e3705472/jobdetailscompanylogo_dd64811c02712599828cc4c462858531_4a7c7e45a350/Petmedix-logo-web.png)
PetMedix
PetMedix is taking the experience of its founding team, and decades of human clinical research, to build platforms that generate fully species-specific, naturally-generated therapeutic antibodies. These platforms have been designed to generate a repertoire of antibodies as diverse as the companion animal immune systems on which they are based. These platforms can then be used to develop a broad pipeline of our own veterinary medicines to target under-served clinical areas that represent excellent market opportunities.